GVK extends biomarker database deal with US FDA

- Last updated on GMT

Related tags: Contract research organization, Food and drug administration

Indian contract research organisation (CRO) GVK Biosciences has granted the US FDA continued access to its biomarker database in an extension of the organisations’ existing agreement.

GVK’s database, known as GioBiom, contains information on biomarkers that are currently being examined in preclinical development or clinical trials at sites around the world.

Under the extended deal, specifics of which have not been disclosed, the US Food and Drug Administration (FDA) will use the information to further develop its guidance on biomarker qualification, a draft version of which was published last October​.

GVK has worked with the FDA since 2007 when it granted the agency’s genomics group access to its database of clinical biomarkers for use in the development of its voluntary genomics data submission (VGDS) programme.

In the four years since that deal GVK’s database has grown from a list of around 300 compounds to over 12,000 biomarkers across all stages of clinical and clinical development.

Related news

Show more

Related products

show more

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 01-Nov-2021 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Related suppliers

Follow us


View more